Title : Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells.

Pub. Date : 2011 Nov 8

PMID : 21970876






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: The combination of the reversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) erlotinib with gemcitabine obtained FDA approval for treating patients with pancreatic cancer. gemcitabine epidermal growth factor receptor Homo sapiens
2 BACKGROUND: The combination of the reversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) erlotinib with gemcitabine obtained FDA approval for treating patients with pancreatic cancer. gemcitabine epidermal growth factor receptor Homo sapiens